Signal transduction by protease‐activated receptors

The family of G protein‐coupled receptors (GPCRs) constitutes the largest class of signalling receptors in the human genome, controlling vast physiological responses and are the target of many drugs. After activation, GPCRs are rapidly desensitized by phosphorylation and β‐arrestin binding. Most classic GPCRs are internalized through a clathrin, dynamin and β‐arrestin‐dependent pathway and then recycled back to the cell surface or sorted to lysosomes for degradation. Given the vast number and diversity of GPCRs, different mechanisms are likely to exist to precisely regulate the magnitude, duration and spatial aspects of receptor signalling. The G protein‐coupled protease‐activated receptors (PARs) provide elegant examples of GPCRs that are regulated by distinct desensitization and endocytic sorting mechanisms, processes that are critically important for the spatial and temporal fidelity of PAR signalling. PARs are irreversibly activated through proteolytic cleavage and transmit cellular responses to extracellular proteases. Activated PAR1 internalizes through a clathrin‐ and dynamin‐dependent pathway independent of β‐arrestins. Interestingly, PAR1 is basally ubiquitinated and deubiquitinated after activation and traffics from endosomes to lysosomes independent of ubiquitination. In contrast, β‐arrestins mediate activated PAR2 internalization and function as scaffolds that promote signalling from endocytic vesicles. Moreover, activated PAR2 is modified with ubiquitin, which facilitates lysosomal degradation. Activated PARs also adopt distinct active conformations that signal to diverse effectors and are likely regulated by different mechanisms. Thus, the identification of the molecular machinery important for PAR signal regulation will enable the development of new strategies to manipulate receptor signalling and will provide novel targets for the development of drugs.

[1]  J. Trejo,et al.  Phosphorylation of Protease-activated Receptor-2 Differentially Regulates Desensitization and Internalization* , 2009, The Journal of Biological Chemistry.

[2]  M. Hollenberg,et al.  Agonist-Biased Signaling via Proteinase Activated Receptor-2: Differential Activation of Calcium and Mitogen-Activated Protein Kinase Pathways , 2009, Molecular Pharmacology.

[3]  M. Hung,et al.  Crosstalk between Protease-activated Receptor 1 and Platelet-activating Factor Receptor Regulates Melanoma Cell Adhesion Molecule (MCAM/MUC18) Expression and Melanoma Metastasis* , 2009, The Journal of Biological Chemistry.

[4]  G. Cottrell,et al.  Endosomal Deubiquitinating Enzymes Control Ubiquitination and Down-regulation of Protease-activated Receptor 2* , 2009, The Journal of Biological Chemistry.

[5]  J. Trejo,et al.  Thrombin Promotes Release of ATP from Lung Epithelial Cells through Coordinated Activation of Rho- and Ca2+-dependent Signaling Pathways* , 2009, The Journal of Biological Chemistry.

[6]  V. Trivedi,et al.  Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand Site , 2009, Cell.

[7]  J. Trejo,et al.  Caveolae are required for protease-selective signaling by protease-activated receptor–1 , 2009, Proceedings of the National Academy of Sciences.

[8]  P. Sexton,et al.  Modulating receptor function through RAMPs: can they represent drug targets in themselves? , 2009, Drug discovery today.

[9]  J. Trejo,et al.  Proteases display biased agonism at protease-activated receptors: location matters! , 2009, Molecular interventions.

[10]  C. Flordellis,et al.  Parstatin, the Cleaved Peptide on Proteinase-Activated Receptor 1 Activation, Is a Potent Inhibitor of Angiogenesis , 2009, Journal of Pharmacology and Experimental Therapeutics.

[11]  Raymond C Stevens,et al.  Discovery of new GPCR biology: one receptor structure at a time. , 2009, Structure.

[12]  C. Brinckerhoff,et al.  Matrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesis. , 2008, The American journal of pathology.

[13]  S. Emr,et al.  Arrestin-Related Ubiquitin-Ligase Adaptors Regulate Endocytosis and Protein Turnover at the Cell Surface , 2008, Cell.

[14]  H. Pelham,et al.  Arrestin-like proteins mediate ubiquitination and endocytosis of the yeast metal transporter Smf1 , 2008, EMBO reports.

[15]  M. Hollenberg,et al.  Analysis of Proteinase-activated Receptor 2 and TLR4 Signal Transduction , 2008, Journal of Biological Chemistry.

[16]  A. Tobin,et al.  Location, location, location…site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling , 2008, Trends in pharmacological sciences.

[17]  C. E. Alvarez On the origins of arrestin and rhodopsin , 2008, BMC Evolutionary Biology.

[18]  M. Yepes,et al.  Plasmin Potentiates Synaptic N-Methyl-D-aspartate Receptor Function in Hippocampal Neurons through Activation of Protease-activated Receptor-1* , 2008, Journal of Biological Chemistry.

[19]  P. Cullen Endosomal sorting and signalling: an emerging role for sorting nexins , 2008, Nature Reviews Molecular Cell Biology.

[20]  W. Greenlee,et al.  Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity. , 2008, Journal of medicinal chemistry.

[21]  T. Hökfelt,et al.  Postendocytotic traffic of the galanin R1 receptor: A lysosomal signal motif on the cytoplasmic terminus , 2008, Proceedings of the National Academy of Sciences.

[22]  J. Chun,et al.  Dendritic cell PAR1–S1P3 signalling couples coagulation and inflammation , 2008, Nature.

[23]  J. Niu,et al.  Zyxin is involved in thrombin signaling via interaction with PAR‐1 receptor , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  J A Peters,et al.  Guide to Receptors and Channels (GRAC), 3rd edition , 2008, British journal of pharmacology.

[25]  A. Marchese,et al.  G protein-coupled receptor sorting to endosomes and lysosomes. , 2008, Annual review of pharmacology and toxicology.

[26]  M. von Zastrow,et al.  Regulation of GPCRs by endocytic membrane trafficking and its potential implications. , 2008, Annual review of pharmacology and toxicology.

[27]  C. Derian,et al.  'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage , 2007, Nature Immunology.

[28]  J. Bae,et al.  The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells. , 2007, Blood.

[29]  A. Malik,et al.  Dual Regulation of Endothelial Junctional Permeability , 2007, Science's STKE.

[30]  R. Piper,et al.  Biogenesis and function of multivesicular bodies. , 2007, Annual review of cell and developmental biology.

[31]  G. Reiser,et al.  p24A, a Type I Transmembrane Protein, Controls ARF1-dependent Resensitization of Protease-activated Receptor-2 by Influence on Receptor Trafficking* , 2007, Journal of Biological Chemistry.

[32]  G. Cottrell,et al.  Hepatocyte Growth Factor-regulated Tyrosine Kinase Substrate (HRS) Mediates Post-endocytic Trafficking of Protease-activated Receptor 2 and Calcitonin Receptor-like Receptor* , 2007, Journal of Biological Chemistry.

[33]  A. Marchese,et al.  Ubiquitination differentially regulates clathrin-dependent internalization of protease-activated receptor-1 , 2007, The Journal of cell biology.

[34]  U. Pendurthi,et al.  Modulation of Tissue Factor–Factor VIIa Signaling by Lipid Rafts and Caveolae , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[35]  J. Trejo,et al.  Clathrin‐Dependent Mechanisms of G Protein‐coupled Receptor Endocytosis , 2007, Traffic.

[36]  S. Ferguson Phosphorylation-independent attenuation of GPCR signalling. , 2007, Trends in pharmacological sciences.

[37]  A. Malik,et al.  Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization , 2007, Proceedings of the National Academy of Sciences.

[38]  J. Bae,et al.  Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells , 2007, Proceedings of the National Academy of Sciences.

[39]  S. Milano,et al.  Regulation of receptor trafficking by GRKs and arrestins. , 2007, Annual review of physiology.

[40]  Arthur Christopoulos,et al.  Functional Selectivity and Classical Concepts of Quantitative Pharmacology , 2007, Journal of Pharmacology and Experimental Therapeutics.

[41]  M. Amorim,et al.  Nuclear Export of Influenza A Virus mRNAs Requires Ongoing RNA Polymerase II Activity , 2007, Traffic.

[42]  V. Gurevich,et al.  The structural basis of arrestin-mediated regulation of G-protein-coupled receptors. , 2006, Pharmacology & therapeutics.

[43]  J. Bonifacino,et al.  The retromer subunit Vps26 has an arrestin fold and binds Vps35 through its C-terminal domain , 2006, Nature Structural &Molecular Biology.

[44]  D. Siderovski,et al.  Clathrin Adaptor AP2 Regulates Thrombin Receptor Constitutive Internalization and Endothelial Cell Resensitization , 2006, Molecular and Cellular Biology.

[45]  G. Reiser,et al.  Jab1, a Novel Protease-activated Receptor-2 (PAR-2)-interacting Protein, Is Involved in PAR-2-induced Activation of Activator Protein-1* , 2006, Journal of Biological Chemistry.

[46]  T. Magnuson,et al.  An essential role for SNX1 in lysosomal sorting of protease-activated receptor-1: evidence for retromer-, Hrs-, and Tsg101-independent functions of sorting nexins. , 2005, Molecular biology of the cell.

[47]  S. Coughlin,et al.  Protease‐activated receptors in hemostasis, thrombosis and vascular biology , 2005, Journal of thrombosis and haemostasis : JTH.

[48]  H. Hamm,et al.  Functional Selectivity of G Protein Signaling by Agonist Peptides and Thrombin for the Protease-activated Receptor-1*[boxs] , 2005, Journal of Biological Chemistry.

[49]  J. Garcia,et al.  Activated Protein C Mediates Novel Lung Endothelial Barrier Enhancement , 2005, Journal of Biological Chemistry.

[50]  Robert J. Lefkowitz,et al.  Transduction of Receptor Signals by ß-Arrestins , 2005, Science.

[51]  G. Cottrell,et al.  c-Cbl Mediates Ubiquitination, Degradation, and Down-regulation of Human Protease-activated Receptor 2* , 2005, Journal of Biological Chemistry.

[52]  C. Feistritzer,et al.  Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. , 2005, Blood.

[53]  V. Jala,et al.  Phosphorylation-independent β-Arrestin Translocation and Internalization of Leukotriene B4 Receptors* , 2005, Journal of Biological Chemistry.

[54]  J. Trejo,et al.  Multiple Independent Functions of Arrestins in the Regulation of Protease-Activated Receptor-2 Signaling and Trafficking , 2005, Molecular Pharmacology.

[55]  R. Lefkowitz,et al.  Constitutive Protease-activated Receptor-2-mediated Migration of MDA MB-231 Breast Cancer Cells Requires Both β-Arrestin-1 and -2* , 2004, Journal of Biological Chemistry.

[56]  Judith Klumperman,et al.  Sorting Nexin-1 Mediates Tubular Endosome-to-TGN Transport through Coincidence Sensing of High- Curvature Membranes and 3-Phosphoinositides , 2004, Current Biology.

[57]  J. Trejo,et al.  A Tyrosine-based Sorting Signal Regulates Intracellular Trafficking of Protease-activated Receptor-1 , 2004, Journal of Biological Chemistry.

[58]  M. Laburthe,et al.  Protease-activated Receptor 2 in Colon Cancer , 2004, Journal of Biological Chemistry.

[59]  S. Coughlin,et al.  Regulated Shedding of PAR1 N-terminal Exodomain from Endothelial Cells* , 2004, Journal of Biological Chemistry.

[60]  J. Trejo,et al.  Termination of Protease-activated Receptor-1 Signaling by β-Arrestins Is Independent of Receptor Phosphorylation* , 2004, Journal of Biological Chemistry.

[61]  J. Bonifacino,et al.  Signals for sorting of transmembrane proteins to endosomes and lysosomes. , 2003, Annual review of biochemistry.

[62]  D. Roosterman,et al.  Rab5a and rab11a mediate agonist-induced trafficking of protease-activated receptor 2. , 2003, American journal of physiology. Cell physiology.

[63]  W. Ruf,et al.  Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway , 2002, Science.

[64]  C. Haft,et al.  Down-regulation of protease-activated receptor-1 is regulated by sorting nexin 1. , 2002, Molecular biology of the cell.

[65]  H. Hamm,et al.  Aspartic Acid 564 in the Third Cytoplasmic Loop of the Luteinizing Hormone/Choriogonadotropin Receptor Is Crucial for Phosphorylation-independent Interaction with Arrestin2* , 2002, The Journal of Biological Chemistry.

[66]  T. Kohout,et al.  β-Arrestins Regulate Protease-activated Receptor-1 Desensitization but Not Internalization or Down-regulation* , 2002, The Journal of Biological Chemistry.

[67]  G. Christ,et al.  Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. , 2001, The Journal of biological chemistry.

[68]  V. Mahajan,et al.  Thrombin Receptor Signaling to Cytoskeleton Requires Hsp90* , 2001, The Journal of Biological Chemistry.

[69]  D. Morrison,et al.  Interleukin-6 production by endothelial cells via stimulation of protease-activated receptors is amplified by endotoxin and tumor necrosis factor-alpha. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[70]  R. Scarborough,et al.  Extracellular mutations of protease-activated receptor-1 result in differential activation by thrombin and thrombin receptor agonist peptide. , 2000, Molecular pharmacology.

[71]  P. Nurden,et al.  The Cleaved Peptide of PAR1 Results in a Redistribution of the Platelet Surface GPIb-IX-V Complex to the Surface-Connected Canalicular System , 2000, Thrombosis and Haemostasis.

[72]  V. Mahajan,et al.  Creatine kinase, an ATP-generating enzyme, is required for thrombin receptor signaling to the cytoskeleton. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[73]  S. Coughlin,et al.  Protease-activated Receptor-1 Down-regulation , 2000, The Journal of Biological Chemistry.

[74]  M. Furman,et al.  GPIIb-IIIa Antagonist-induced Reduction in Platelet Surface Factor V/Va Binding and Phosphatidylserine Expression in Whole Blood , 2000, Thrombosis and Haemostasis.

[75]  S. Coughlin,et al.  Protease-activated Receptors 1 and 4 Are Shut Off with Distinct Kinetics after Activation by Thrombin* , 2000, The Journal of Biological Chemistry.

[76]  A. Malik,et al.  G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[77]  N. Prévost,et al.  Thrombin Responses in Human Endothelial Cells , 2000, The Journal of Biological Chemistry.

[78]  S. Coughlin,et al.  PAR3 is a cofactor for PAR4 activation by thrombin , 2000, Nature.

[79]  R. Mullins,et al.  β-Arrestin–Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2 , 2000, The Journal of cell biology.

[80]  N. Bunnett,et al.  Trafficking of Proteinase-activated Receptor-2 and β-Arrestin-1 Tagged with Green Fluorescent Protein , 1999, The Journal of Biological Chemistry.

[81]  P. Sigler,et al.  A Model for Arrestin’s Regulation: The 2.8 Å Crystal Structure of Visual Arrestin , 1999, Cell.

[82]  C. Costello,et al.  Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. , 1999, Biochemistry.

[83]  Jie Zhang,et al.  The β2-adrenergic receptor/βarrestin complex recruits the clathrin adaptor AP-2 during endocytosis , 1999 .

[84]  S. Coughlin,et al.  The Cytoplasmic Tails of Protease-activated Receptor-1 and Substance P Receptor Specify Sorting to Lysosomes versusRecycling* , 1999, The Journal of Biological Chemistry.

[85]  S. Coughlin,et al.  Termination of signaling by protease-activated receptor-1 is linked to lysosomal sorting. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[86]  M. Grossmann,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[87]  D. Payan,et al.  Mechanisms of Desensitization and Resensitization of Proteinase-activated Receptor-2* , 1996, The Journal of Biological Chemistry.

[88]  A. Roth,et al.  Ubiquitination of the yeast a-factor receptor , 1996, The Journal of cell biology.

[89]  S. Coughlin,et al.  Agonist Recognition by Proteinase-activated Receptor 2 and Thrombin Receptor , 1996, The Journal of Biological Chemistry.

[90]  A. Ullrich,et al.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors , 1996, Nature.

[91]  Howard Riezman,et al.  Ubiquitination of a Yeast Plasma Membrane Receptor Signals Its Ligand-Stimulated Endocytosis , 1996, Cell.

[92]  B. Kobilka,et al.  Intracellular targeting and trafficking of thrombin receptors. A novel mechanism for resensitization of a G protein-coupled receptor. , 1994, The Journal of biological chemistry.

[93]  J. Chen,et al.  Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. , 1994, The Journal of biological chemistry.

[94]  N. Nathanson,et al.  Differential role of the carboxyl-terminal tyrosine in down-regulation and sequestration of the m2 muscarinic acetylcholine receptor. , 1994, The Journal of biological chemistry.

[95]  C. Turck,et al.  Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface , 1994, Nature.

[96]  J. Chen,et al.  Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. Functional specificity among G-protein coupled receptor kinases. , 1994, The Journal of biological chemistry.

[97]  B. Kobilka,et al.  Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling. , 1993, The Journal of biological chemistry.

[98]  V. Wheaton,et al.  Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. , 1992, The Journal of biological chemistry.

[99]  M. Caron,et al.  Desensitization of the isolated beta 2-adrenergic receptor by beta-adrenergic receptor kinase, cAMP-dependent protein kinase, and protein kinase C occurs via distinct molecular mechanisms. , 1992, Biochemistry.

[100]  V. Wheaton,et al.  Domains specifying thrombin–receptor interaction , 1991, Nature.

[101]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[102]  J. Ramachandran,et al.  Structure and Function of G Protein Coupled Receptors , 1990, Pharmaceutical Research.

[103]  M. Caron,et al.  beta-Arrestin: a protein that regulates beta-adrenergic receptor function. , 1990, Science.

[104]  H. Hamm,et al.  Heterotrimeric G protein activation by G-protein-coupled receptors , 2008, Nature Reviews Molecular Cell Biology.

[105]  H. Hamm,et al.  How do receptors activate G proteins? , 2007, Advances in protein chemistry.

[106]  David Owen,et al.  Life of a clathrin coat: insights from clathrin and AP structures , 2006, Nature Reviews Molecular Cell Biology.

[107]  J. Griffin,et al.  bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use only. The cytoprotective protein C pathway , 2006 .

[108]  J. Griffin,et al.  Activated protein C variants with normal cytoprotective but reduced anticoagulant activity. , 2004, Blood.

[109]  M. Hollenberg,et al.  Proteinase-activated receptor-2: key role of amino-terminal dipeptide residues of the tethered ligand for receptor activation. , 2004, Molecular pharmacology.

[110]  S. Coughlin,et al.  PARticipation in inflammation. , 2003, The Journal of clinical investigation.

[111]  J. Reny,et al.  Hemostasis, Thrombosis, and Vascular Biology , 2022 .

[112]  S. Coughlin,et al.  A MUTANT HeLa CELL LINE SUGGESTS NOVEL REQUIREMENTS FOR PAR1 PHOSPHORYLATION AND RECRUITMENT TO CLATHRIN-COATED PITS* , 2000 .

[113]  A. Ullrich,et al.  EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF , 1999, Nature.

[114]  P. Sigler,et al.  The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation. , 1999, Cell.

[115]  J. Benovic,et al.  The role of receptor kinases and arrestins in G protein-coupled receptor regulation. , 1998, Annual review of pharmacology and toxicology.

[116]  J. Benovic,et al.  Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. , 1996, Nature.

[117]  E. Simons,et al.  Thrombin receptors on human platelets. , 1992, Methods in enzymology.

[118]  S. Coughlin,et al.  PAR 3 is a cofactor for PAR 4 activation by thrombin , 2022 .